Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide

Journal of Leukocyte Biology

Volumn 96, Issue 5, 2014, Pages 675-684

  Liao, Jiongbo ^a,b   Wang, Xiao ^b   Bi, Yujing ^d   Shen, B ^c   Shao, Kun ^a,b   Yang, Hui ^b   Lu, Yun ^b   Zhang, Zhengguo ^b   Chen, X ^b   Liu, Huanrong ^b   Wang, Jian ^b   Chu, Yiwei ^b   Xue, Lixiang ^e   Wang, Xianghui ^a   Liu, Guangwei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c FUDAN UNIVERSITY   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Glucocorticoids; Graft rejection; Innate immunity; Th1 cells; Tolerance; Tregs

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HERMES ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; L SELECTIN; MESSENGER RNA; MIFEPRISTONE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; CELL SURFACE RECEPTOR; GRANULOCYTE RECEPTOR 1, MOUSE; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DEATH; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GRAFT REJECTION; GRAFT SURVIVAL; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION; ALLOGRAFT; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; FEMALE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PHENOTYPE; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ALLOGRAFTS; ANIMALS; ANTIGENS, CD11B; ANTIGENS, SURFACE; CELL DIFFERENTIATION; DEXAMETHASONE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MICE; MYELOID CELLS; NITRIC OXIDE; PHENOTYPE; RECEPTORS, CELL SURFACE; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 84907277761     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2HI1113-611RR     Document Type: Article

References (41)

1. Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., Clark, A. R. (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883–1889.
2. Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K., Muglia, L. J. (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313–4319.
3. Hackstein, H., Thomson, A. W. (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4, 24–34.
4. Zheng G., Zhong, S., Geng, Y., Munirathinam, G., Cha, I., Reardon, C., Getz, G. S., Van, Rooijen N., Kang, Y., Wang, B., Chen, A. (2013) Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur. J. Immunol. 43, 219–227.
5. Kang, Y., Xu, L., Wang, B., Chen, A., Zheng, G. (2008) Cutting edge: immunosuppressant as adjuvant for tolerogenic immunization. J. Immunol. 180, 5172–5176.
6. Almawi, W. Y., Hess, D. A., Rieder, M. J. (1998) Multiplicity of glucocorticoid action in inhibiting allograft rejection. Cell Transplant. 7, 511–523.
7. Almawi, W. Y., Melemedjian, O. K., Rieder, M. J. (1999) An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin. Transplant. 13, 365–374.
8. Ray, P., Arora, M., Poe, S. L., Ray, A. (2012) Lung myeloid-derived suppressor cells and regulation of inflammation. Immunol. Res. 50, 153–158.
9. Liu, G., Bi, Y., Shen, B., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Liao, J., Chen, X., Chu, Y. (2014) SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis. Cancer Res. 74, 727–737.
10. Ostrand-Rosenberg, S., Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499–4506.
11. Jayaraman, P., Parikh, F., Lopez-Rivera, E., Hailemichael, Y., Clark, A., Ma, G., Cannan, D., Ramacher, M., Kato, M., Overwijk, W. W., Chen, S. H., Umansky, V. Y., Sikora, A. G. (2010) Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J. Immunol. 188, 5365–5376.
12. Van, Rompaey N., Le Moine, A. (2010) Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation. Methods Mol. Biol. 677, 169–180.
13. Dugast, A. S., Haudebourg, T., Coulon, F., Heslan, M., Haspot, F., Poirier, N., Vuillefroy, D. E., Silly, R., Usal, C., Smit, H., Martinet, B., Thebault, P., Renaudin, K., Vanhove, B. (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 180, 7898–7906.
14. Garcia, M. R., Ledgerwood, L., Yang, Y., Xu, J., Lal, G., Burrell, B., Ma, G., Hashimoto, D., Li, Y., Boros, P., Grisotto, M., Van Rooijen, N., Matesanz, R., Tacke, F., Ginhoux, F., Ding, Y., Chen, S. H., Randolph, G., Merad, M., Bromberg, J. S., Ochando, J. C. (2010) Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120, 2486–2496.
15. Luan, Y., Mosheir, E., Menon, M. C., Wilson, D., Woytovich, C., Ochando, J., Murphy, B. (2013) Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. Am. J. Transplant. 13, 3123–3131.
16. Rosenberg, A. S., Mizuochi, T., Singer, A. (1988) Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants. J. Exp. Med. 168, 33–45.
17. Rosenberg, A. S., Munitz, T. I., Maniero, T. G., Singer, A. (1991) Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8_ T cells in vivo. J. Exp. Med. 173, 1463–1471.
18. Mayumi, H., Nomoto, K., Good, R. A. (1988) A surgical technique for experimental free skin grafting in mice. Jpn. J. Surg. 18, 548–557.
19. Corry, R. J., Winn, H. J., Russell, P. S. (1973) Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16, 343–350.
20. Siemionow, M., Demir, Y., Mukherjee, A., Klimczak, A. (2005) Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation 79, 558–567.
21. Sun, B., Hu, X., Liu, G., Ma, B., Xu, Y., Yang, T., Shi, J., Yang, F., Li, H., Zhang, L., Zhao, Y. (2014) Phosphatase Wip1 negatively regulates neutrophil migration and inflammation. J. Immunol. 192, 1184–1195.
22. Schumann, J., Prockl, J., Kiemer, A. K., Vollmar, A. M., Bang, R., Tiegs, G. (2003) Silibinin protects mice from T cell-dependent liver injury. J. Hepatol. 39, 333–340.
23. Cripps, J. G., Wang, J., Maria, A., Blumenthal, I., Gorham, J. D. (2010) Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 52, 1350–1359.
24. Liu, G., Burns, S., Huang, G., Boyd, K., Proia, R.l., Flavell, R.A., Chi, H. (2009) The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769–777.
25. Liu, G., Bi, Y., Wang, R., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Zhang, Z., Chen, W., Chu, Y., Yang, R. (2014) Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloidderived suppressor cells. J. Immunol. 192, 3068–3079.
26. Liu, G., Ma, H., Qiu, L., Li, L., Cao, Y., Ma, J., Zhao, Y. (2011) Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89, 130–142.
27. Liu, G., Hu, X., Sun, B., Yang, T., Shi, J., Zhang, L., Zhao, Y. (2013) Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT 1. Blood 121, 519–529.
28. Liu, G., Bi, Y., Wang, R., Shen, B., Zhang, Y., Yang, H., Wang, X., Liu, H., Lu, Y., Han, F. (2013) Kinase AKT1 negatively controls neutrophil recruitment and function in mice. J. Immunol. 191, 2680–2690.
29. Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., Linke, R. P., Muller, M., Blander, J. M., Tacke, F., Trautwein, C. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453–1464.
30. Chen, H. W., Chen, H. Y., Wang, L. T., Wang, F. H., Fang, L.W., Lai, H. Y., Chen, H. H., Lu, J., Hung, M. S., Cheng, Y., Chen, M. Y., Liu, S. J., Chong, P., Lee, O. K., Hsu, S. C. (2013) Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid- derived suppressive phenotype through growth-regulated oncogene chemokines. J. Immunol. 190, 5065–5077.
31. Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., Cerwenka, A. (2012) Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J. Immunol. 189, 5602–5011.
32. Dilek, N., Poirier, N., Usal, C., Martinet, B., Blancho, G., Vanhove, B. (2012) Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL 5. J. Immunol. 188, 4209–4216.
33. Kodumudi, K. N., Weber, A., Sarnaik, A. A., Pilon-Thomas, S. (2011) Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma. J. Immunol. 189, 5147–5154.
34. Chen, S., Akbar, S. M., Abe, M., Hiasa, Y., Onji, M. (2011) Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin. Exp. Immunol. 166, 134–142.
35. Mirani, M., Elenkov, I., Volpi, S., Hiroi, N., Chrousos, G. P., Kino, T. (2012) HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J. Immunol. 169, 6361–6368.
36. Kino, T., Chrousos, G. P. (2001) Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J. Endocrinol. 169, 437–445.
37. Zhang, K., Bai, X., Li, R., Xiao, Z., Chen, J., Yang, F., Li, Z. (2012) Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma. Int. J. Mol. Med. 30, 277–282.
38. Barczyk, K., Ehrchen, J., Tenbrock, K., Ahlmann, M., Kneidl, J., Viemann, D., Roth, J. (2010) Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A 3. Blood 116, 446–455.
39. Ehrchen, J., Steinmuller, L., Barczyk, K., Tenbrock, K., Nacken, W., Eisenacher, M., Nordhues, U., Sorg, C., Sunderkotter, C., Roth, J. (2007) Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265–1274.
40. Varga, G., Ehrchen, J., Tsianakas, A., Tenbrock, K., Rattenholl, A., Seeliger, S., Mack, M., Roth, J., Sunderkoetter, C. (2008) Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J. Leukoc. Biol. 84, 644–650.
41. Rearte, B., Maglioco, A., Balboa, L., Bruzzo, J., Landoni, V. I., Laborde, E. A., Chiarella, P., Ruggiero, R. A., Fernandez, G. C., Isturiz, M. A. (2010) Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clin. Exp. Immunol. 162, 568–577.